CAMILLE CLARE MD MPH CPE FACOGMar 28, 2024
https://letsconnectacogdistrict2.buzzsprout.com/1774965/14779330 Check out our podcast on #colorectalcancer screening by #obgyns #colorectalcancerawarenessmonth #ObGynodon
Let's Connect - Why Colorectal Cancer Screening is Important for Ob-Gyn Practice - Let's Connect an ACOG District II Podcast Series

This podcast episode hosted by Camille A. Clare, MD, MPH, CPE, FACOG, District II past chair, includes ob-gyn and gastro-enterologist experts sharing the latest data, discussing the inequalities and disparities that persist amongst Black patients,...

Buzzsprout
CAMILLE CLARE MD MPH CPE FACOGNov 12, 2023
Anyone still on here 🤷🏽‍♀️🤷🏽‍♀️ #ObGynodon #johnmastodon
CAMILLE CLARE MD MPH CPE FACOGNov 7, 2023
Anyone still here #ObGynodon 🤷🏽‍♀️🤷🏽‍♀️
Kevin AultSep 6, 2023

“This isn’t an issue about #abortion,” said Dr. Stella Dantas, the president-elect of the American College of Obstetricians and Gynecologists. “This is an issue about access to comprehensive obstetric and gynecologic care. When you restrict access to care that is based in science, that everybody should have access to — that has a ripple effect.”

#ObGynodon & #MedMastodon

https://www.nytimes.com/2023/09/06/us/politics/abortion-obstetricians-maternity-care.html?unlocked_article_code=KXij_dBnhwEem9DX3cnUHRXl7MmCxA9FQwwiXN6xM9hY6S-pw5t6rfKJzS_WsyEkCTFU4uTu_B5ZPDzO4nYvki_EaTz55pLTDi9laT-UTEmbdwv9DS7aYasmnfPueGDISXkiKFV-GkmNNVuTf07gxhmxeYB47UwYP69zx1VQm7yGhcNLxIY3vc1OMyh6QLh-rli4PAlPAEsnVTkbKET_1v0Fio2o6pUHE6yNb7T4tOFNwwPNAkT3NMrWDYKPq76xTokENOb-3HbmUaOSVIbDIUI5DHVRhpwgpxieT8QZIsbUuDZ8CcGZ89XjoJ40KiltMLSq5gz4DdN4bPlPWs7DwCfOcAsdlSwgSncExCdFvmotKqg&smid=url-share

As Abortion Laws Drive Obstetricians From Red States, Maternity Care Suffers

Some doctors who handle high-risk pregnancies are fleeing restrictive abortion laws. Idaho has been particularly hard hit.

The New York Times
Kevin AultSep 2, 2023

"And CPCs’ activities are increasingly being bankrolled by the government. At least 18 states have funded them at some point. Since 2010, 13 of those states have given CPCs about $495 million."

I can think of many better ways to spend one billion dollars a year - #Obgynodon. https://rewirenewsgroup.com/2023/08/30/anti-abortion-centers-spent-over-600m-in-one-year-thats-the-tip-of-the-iceberg/

Anti-Abortion Centers Spent Over $600M in One Year. That's the Tip of the Iceberg.

Documents reviewed by Rewire News Group suggest the total may have been closer $1 billion. Where is all that "crisis pregnancy center" money going?

Rewire News Group
Kevin AultAug 27, 2023
"The most frequently reported reasons for hesitancy among #pregnant and #breastfeeding women were concerns about safety of the vaccine for pregnant/breastfeeding women or their baby, the perception of a rapid vaccine development and approval process, and a lack of knowledge/information about the vaccine. As a matter of fact, healthcare professionals’ trust in vaccines and their recommendations to people is of paramount importance" - #ObGynodon & #IDMastodon - https://www.mdpi.com/2076-393X/11/8/1289
A Systematic Review of Population-Based Studies Assessing Knowledge, Attitudes, Acceptance, and Hesitancy of Pregnant and Breastfeeding Women towards the COVID-19 Vaccine

The anti-SARS-CoV-2 vaccination is recommended for pregnant women due to the high risk of complications. However, pregnancy has been associated with vaccine hesitancy. Our review aims at summarizing the existing literature about anti-SARS-CoV-2 vaccine hesitancy in pregnant and lactating women. The research was conducted on PubMed/MEDLINE, ExcerptaMedica Database (EMBASE), and Scopus, according to PRISMA guidelines. Articles regarding the COVID-19 vaccine’s acceptance and/or refusal by pregnant and lactating women were selected. Only observational, population-based studies were included. The Joanna Briggs Institute quality assessment tools were employed. A total of 496 articles were retrieved, and after the selection process, 21 papers were included in the current analysis. All the included studies were cross-sectional, mostly from Europe and North America. The sample sizes ranged between 72 and 25,111 subjects. All of them included pregnant subjects, except one that focused on breastfeeding women only. Vaccine hesitancy rates ranged from 26% to 57% among different studies. Fear of adverse events and lack of knowledge were shown to be the main drivers of hesitancy. Approximately half of the studies (11/21) were classified as low quality, the remaining (9/21) were classified as moderate, and only one study was classified as high quality. Primigravidae were also shown to be more likely to accept anti-SARS-CoV-2 vaccination. Our findings confirm significant anti-SARS-CoV-2 vaccine hesitancy among pregnant women. Information gaps should be addressed to contain concerns related to adverse events.

MDPI
Jiří VojtěchAug 26, 2023

Vasa Previa: Natural history, Clinical presentation and Management

↪️ https://journals.lww.com/greenjournal/fulltext/2023/09000/vasa_previa.9.aspx

via #TheGreenJournal

#ObGyn #obgynodon #PerinatalHealth #vasaprevia #bleeding #pregnancy

Vasa Previa : Obstetrics & Gynecology

sible to diagnose the condition prenatally, allowing cesarean delivery before labor or rupture of the membranes. Several recent studies have indicated excellent outcomes with prenatally diagnosed vasa previa. However, outcomes continue to be dismal when vasa previa is undiagnosed before labor. Risk factors for vasa previa include second-trimester placenta previa and low-lying placentas, velamentous cord insertion, placentas with accessory lobes, in vitro fertilization, and multifetal gestations. Recognition of individuals who are at risk and screening them will greatly decrease the mortality rate from this condition. Because of the relative rarity of vasa previa, there are no randomized controlled trials to guide management. Therefore, recommendations on the diagnosis and management of vasa previa are based largely on cohort studies and expert opinion. This Clinical Expert Series review addresses the epidemiology, pathophysiology, natural history, diagnosis and management of vasa previa, as well as innovative treatments for the condition....

LWW
Jiří VojtěchAug 23, 2023

COMMENTARY: CONSENSUS STATEMENT
Consensus Bundle on Sepsis in Obstetric Care

↪️ https://journals.lww.com/greenjournal/fulltext/2023/09000/alliance_for_innovation_on_maternal_health_.7.aspx

via #TheGreenJournal 🟢

- Readiness
- Recognition
- Response
- Reporting
- Respectful care

#ObGyn #obgynodon #PerinatalHealth #sepsis #delivery

Alliance for Innovation on Maternal Health: Consensus... : Obstetrics & Gynecology

that deaths are preventable much of the time and are caused by delays in recognition, treatment, and escalation of care. The “Sepsis in Obstetric Care” patient safety bundle provides guidance for health care teams to develop coordinated, multidisciplinary care for pregnant and postpartum people by preventing infection and recognizing and treating infection early to prevent progression to sepsis. This is one of several core patient safety bundles developed by AIM (the Alliance for Innovation on Maternal Health) to provide condition- or event-specific clinical practices that should be implemented in all appropriate care settings. As with other bundles developed by AIM, the “Sepsis in Obstetric Care” patient safety bundle is organized into five domains: Readiness, Recognition and Prevention, Response, Reporting and Systems Learning, and Respectful, Equitable, and Supportive Care. The Respectful, Equitable, and Supportive Care domain provides essential best practices to support respectful, equitable, and supportive care to all patients. Further health equity considerations are integrated into the elements of each domain....

LWW
Kevin AultAug 23, 2023
Long post via Dr. Male of Imperial College / London about the #RSV vaccine... on that other social media platform #IDMastodon #ObGynodon - https://twitter.com/VikiLovesFACS/status/1694336102574800913?s=20
Viki Male on X

🇺🇸 Yesterday, the FDA approved an RSV vaccine for use in pregnancy. There was a non-significant difference in preterm birth in the trial, which patients will be informed about. Let's look at the minutes of the meeting to understand these decisions... 🧵 https://t.co/AfOz0DUnMs

Twitter
Kevin AultAug 22, 2023

earlier today the FDA approved a maternal vaccine for prevention of #RSV in newborns... via @HelenBranswell.

#Obgynodon & #IDMastodon
https://www.statnews.com/2023/08/21/pfizer-rsv-vaccine-abrysvo-newborns-fda-approval/

FDA approves Pfizer's RSV vaccine designed to protect newborns by immunizing parent

The FDA on Monday approved a Pfizer vaccine that aims to protect newborns against RSV by vaccinating pregnant people in the latter part of pregnancy.

STAT